中药调控Keap1/Nrf2/ARE信号通路干预肺纤维化的研究进展

    Research Progress on Traditional Chinese Medicine Regulating the Keap1/Nrf2/ARE Signaling Pathway to Intervene in Pulmonary Fibrosis

    • 摘要: 肺纤维化(pulmonary fibrosis,PF)是一种慢性进行性的呼吸系统疾病,其发病率会随着年龄的增长而不断增加。氧化应激损伤是PF的重要发病机制,在PF的发生发展中具有重要作用。Kelch样ECH相关蛋白1(Kelch-like ECH-associated protein1,Keap1)/核转录因子E2相关因子2(nuclear factor erythroid 2 related factor 2,Nrf2)/抗氧化反应元件(antioxidant response element,ARE)信号通路是细胞内重要的抗氧化应激途径之一,该通路可以通过调节多种抗氧化酶和解毒酶的表达,对细胞的氧化还原平衡及代谢起到关键作用。研究发现,中药活性成分、提取物、复方及中成药可通过抑制氧化应激损伤、减轻炎症反应等途径发挥抗PF的作用,其作用机制与激活Keap1/Nrf2/ARE信号通路有关。基于此,本文从中药调控Keap1/Nrf2/ARE信号通路治疗PF的作用机制进行综述,为中药治疗PF的新药研究提供参考。

       

      Abstract: Pulmonary fibrosis(PF) is a chronic progressive respiratory disease, the incidence of which increases with age. Oxidative stress damage is an important pathogenesis of PF and plays a significant role in its development. The Kelch-like ECH-associated protein 1(Keap1)/nuclear factor erythroid 2-related factor 2(Nrf2)/antioxidant response element(ARE) signaling pathway is one of the key intracellular antioxidant stress pathways. It regulates the expression of various antioxidant and detoxifying enzymes, playing a crucial role in maintaining cellular redox balance and metabolism. Studies have shown that active components, extracts, compound prescriptions and proprietary Chinese medicine(TCM) can exert anti-PF effects by inhibiting oxidative stress damage and reducing inflammatory responses, with mechanisms related to the activation of the Keap1/Nrf2/ARE signaling pathway. Based on this, this article reviews the mechanisms of TCM regulation of the Keap1/Nrf2/ARE signaling pathway in the treatment of PF, providing references for the development of new TCM drugs for the treatment of PF.

       

    /

    返回文章
    返回